文献速递乳腺癌

腋窝软组织微环境的病理学探索及其对腋窝管理和乳腺癌结局的影响

Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes.
PubMed 文献 · J Clin Oncol · 2023-11-15

该研究分析2162例淋巴结阳性乳腺癌患者,按腋窝病理分为四组,评估腋窝软组织(AXT)受累对10年局部区域失败、腋窝失败和远处转移的影响。中位随访9.4年,多因素分析显示AXT与远处转移(HR 1.6)、局部区域失败(HR 2.3)和腋窝失败(HR 3.3)显著相关。结论强调常规报告AXT至关重要,在腋窝降阶梯治疗前必须排除AXT。

要点

  • AXT与远处转移(HR 1.6)、局部区域失败(HR 2.3)和腋窝失败(HR 3.3)显著相关。
  • 区域淋巴结放疗(RLNR)改善伴有AXT、ECE或两者兼有的局部区域肿瘤结局(HR 0.5)。
  • 在AXT/ECE存在时,腋窝放疗剂量≤50 Gy增加腋窝失败(HR 3.0)。

核心结论

  • 常规报告淋巴结和ECE之外的腋窝组织受累对预测乳腺癌结局至关重要。
  • 在任何形式的腋窝降阶梯治疗(尤其是省略RLNR)之前,必须排除AXT的存在。

研究设计与样本

  • 研究分析了2162例淋巴结阳性(LN+)乳腺癌患者,根据腋窝病理分为四组:仅LN+、仅LN+和ECE、LN+和AXT无ECE、LN+伴AXT和ECE。
  • 主要终点为10年局部区域失败(LRF)、10年腋窝失败和10年远处转移率,使用多因素Cox模型并校正临床因素。

主要发现

  • 10年远处转移发生率:LN+AXT+ECE组42%,LN+AXT和仅LN+ECE组均为23%,仅LN+组13%。
  • 10年腋窝失败率:LN+AXT+ECE组4.5%,LN+AXT组4.6%,仅LN+ECE组0.8%,仅LN+组1.6%。
  • 10年LRF率:LN+AXT+ECE组14%,LN+AXT组10%,仅LN+ECE组5.7%,仅LN+组6.2%。
  • 多因素分析显示AXT与远处转移(HR 1.6;P < .001)、局部区域失败(HR 2.3;P < .001)和腋窝失败(HR 3.3;P = .003)显著相关。
  • 亚组分析显示RLNR改善伴有AXT、ECE或两者的局部区域肿瘤结局(HR 0.5;P = .03);在AXT/ECE存在时腋窝剂量≤50 Gy增加腋窝失败(HR 3.0;P = .04);RLNR时腋窝淋巴结清扫可降阶梯为前哨淋巴结活检而不显著增加失败结局:LRF(HR 1.0;P = .92)、腋窝失败(HR 1.1;P = .94)、远处转移(HR 0.4;P = .01)。

临床怎么用

  • 原文结论强调常规报告腋窝组织受累(超出淋巴结和ECE)对预测乳腺癌结局至关重要,并在任何腋窝降阶梯治疗前必须排除AXT。
  • 亚组分析显示RLNR可改善伴有AXT、ECE或两者的局部区域肿瘤结局;在AXT/ECE存在时腋窝剂量≤50 Gy增加腋窝失败;RLNR时腋窝淋巴结清扫可降阶梯为前哨淋巴结活检而不显著增加失败结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Axillary soft tissue (AXT) involvement with tumor cells extending beyond the positive lymph node (LN+) and extracapsular extension (ECE) has been overlooked in breast pathology specimen analysis. MATERIALS AND METHODS: We analyzed 2,162 LN+ patients, dividing them into four groups on the basis of axillary pathology: (1) LN+ only, (2) LN+ and ECE only, (3) LN+ and AXT without ECE, and (4) LN+ with both AXT and ECE. The primary end points were 10-year locoregional failure (LRF), the 10-year axillary failure, and 10-year distant metastasis rates. Multivariable Cox models, accounting for clinical factors, were fitted using the entire cohort, and subgroups analyses were conducted. RESULTS: The median follow-up was 9.4 years. The 10-year distant metastasis incidence was 42% for LN + AXT + ECE, 23% for both LN + AXT and LN + ECE only, and 13% for LN+ only. The 10-year axillary failure rates were 4.5% for LN + AXT + ECE, 4.6% for LN + AXT, 0.8% for LN + ECE only, and 1.6% for LN+ only. The 10-year LRF rates were 14% for LN + AXT + ECE, 10% for LN + AXT, 5.7% for LN + ECE only, and 6.2% for LN+ only. Multivariable analysis revealed that AXT was significantly associated with distant metastasis (hazard ratio [HR], 1.6; P < .001), locoregional failure (HR, 2.3; P < .001), and axillary failure (HR, 3.3; P = .003). Subgroup analyses showed that regional LN radiation (RLNR) improved locoregional tumor outcomes with AXT, ECE, or both (HR, 0.5; P = .03). Delivering ≤50 Gy to the axilla in the presence of AXT/ECE increased axillary failure (HR, 3.0; P = .04). Moreover, when delivering RLNR, axillary LN dissection could be de-escalated to sentinel node biopsy even in the presence of features such as AXT or ECE without significantly increasing any failure outcome: (HR, 1.0; P = .92) for LRF, (HR, 1.1; P = .94) axillary failure, and (HR, 0.4; P = .01) distant metastasis. CONCLUSION: Routine reporting of axillary tissue involvement, beyond LNs and ECE, is crucial in predicting breast cancer outcomes. Ruling out the presence of AXT is imperative before any form of axillary de-escalation, especially RLNR omission.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Naoum GE, Oladeru O, Ababneh H, et al. Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes. J Clin Oncol. 2023. PMID: 37967296. doi:10.1200/JCO.23.01009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。